Filing metadata

Accession number
0001209191-22-059049
Form type
Form 3
Filer
Keros Therapeutics, Inc.
CIK
CIK 1664710
Filed
Nov 30, 2022
Reporting period
Apr 07, 2020
Description
Initial ownership

Explore SEC Filings Hub